Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Weigel R, Estill J, Egger M, Harries AD, Makombe S, Tweya H, Jahn A, Keiser O.

AIDS. 2012 Jan 28;26(3):365-73. doi: 10.1097/QAD.0b013e32834ed814.

2.

Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.

Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, Spoerri A, Chimbwandira F, van Oosterhout JJ, Keiser O.

Lancet HIV. 2016 Apr;3(4):e175-82. doi: 10.1016/S2352-3018(16)00008-4. Epub 2016 Mar 9.

3.

Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.

Alvarez-Uria G, Naik PK, Pakam R, Midde M.

Glob Health Action. 2013 Sep 12;6:21682. doi: 10.3402/gha.v6i0.21682.

4.

Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Auld AF, Tuho MZ, Ekra KA, Shiraishi RW, Mohamed F, Kouakou JS, Ettiègne-Traoré V, Sabatier J, Essombo J, Rivadeneira ED, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

Pediatr Infect Dis J. 2014 Nov;33(11):1134-40. doi: 10.1097/INF.0000000000000457.

PMID:
25093975
5.

The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.

Cornell M, Myer L, Kaplan R, Bekker LG, Wood R.

Trop Med Int Health. 2009 Jul;14(7):722-31. doi: 10.1111/j.1365-3156.2009.02290.x. Epub 2009 Apr 27.

6.

Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.

Sengayi M, Dwane N, Marinda E, Sipambo N, Fairlie L, Moultrie H.

Glob Health Action. 2013 Jan 24;6:19248. doi: 10.3402/gha.v6i0.19248.

7.

Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.

Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, Mhango E, Nkwazi B, Tweya H, Kamlaka M, Chagwera F, Phiri S.

BMC Infect Dis. 2011 Jan 27;11:31. doi: 10.1186/1471-2334-11-31.

8.

Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.

Ojwang' VO, Penner J, Blat C, Agot K, Bukusi EA, Cohen CR.

AIDS Care. 2016;28(4):500-7. doi: 10.1080/09540121.2015.1110234. Epub 2015 Nov 12.

PMID:
26565428
9.

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, Moultrie H, Prozesky H, Technau K, Eley B, Vaz P, Pascoe M, Giddy J, Van Cutsem G, Wood R, Egger M, Davies MA; International epidemiologic Databases to Evaluate AIDS in Southern Africa..

J Acquir Immune Defic Syndr. 2010 Aug;54(5):524-32. doi: 10.1097/QAI.0b013e3181e0c4cf.

10.

Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.

Tweve EN, Kayabu D, Nassari NO, Todd J.

Trop Med Int Health. 2015 Jun;20(6):791-6. doi: 10.1111/tmi.12488. Epub 2015 Mar 27.

11.

Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

McManus H, O'Connor CC, Boyd M, Broom J, Russell D, Watson K, Roth N, Read PJ, Petoumenos K, Law MG; Australian HIV Observational Database..

PLoS One. 2012;7(11):e48839. doi: 10.1371/journal.pone.0048839. Epub 2012 Nov 7.

12.

Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N, Egger M, Chi BH; Swiss HIV Cohort Study.; IeDEA Southern Africa..

PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919. Epub 2011 Dec 19.

13.

Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.

Thai S, Koole O, Un P, Ros S, De Munter P, Van Damme W, Jacques G, Colebunders R, Lynen L.

Trop Med Int Health. 2009 Sep;14(9):1048-58. doi: 10.1111/j.1365-3156.2009.02334.x. Epub 2009 Jul 2.

14.

Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors.

Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):455-63. doi: 10.1097/QAI.0b013e3182a61e8d.

PMID:
23892242
15.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

PMID:
23100567
16.

Decentralised paediatric HIV care in Ethiopia: a comparison between outcomes of patients managed in health centres and in a hospital clinic.

Hagströmer O, Lundstedt L, Balcha TT, Björkman P.

Glob Health Action. 2013 Nov 11;6:22274. doi: 10.3402/gha.v6i0.22274.

17.

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.

Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R.

Lancet Glob Health. 2014 Jan;2(1):e44-50. doi: 10.1016/S2214-109X(13)70149-9. Epub 2013 Dec 11.

18.

Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.

Brown JP, Ngwira B, Tafatatha T, Crampin AC, French N, Koole O.

AIDS Res Ther. 2016 Jul 8;13:24. doi: 10.1186/s12981-016-0110-2. eCollection 2016.

19.

Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.

Decroo T, Koole O, Remartinez D, dos Santos N, Dezembro S, Jofrisse M, Rasschaert F, Biot M, Laga M.

Trop Med Int Health. 2014 May;19(5):514-21. doi: 10.1111/tmi.12278. Epub 2014 Feb 12.

20.

Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.

Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Touré S, Seyler C, Fassinou P, Dabis F, N'Dri-Yoman T, Anglaret X, Leroy V.

Bull World Health Organ. 2010 Jul 1;88(7):490-9. doi: 10.2471/BLT.09.068015. Epub 2009 Dec 21.

Supplemental Content

Support Center